• SELECT SITE CURRENCY
Select a currency for use throughout the site
Shanghai No. 1 Pharmaceutical Company Limited
Wright Investors Service, May 2013, Pages: 40
Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality Rating analyses tables. The Wright Quality Rating, a measure of corporate risk, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of Shanghai No. 1 Pharmaceutical Company Limited. There is a textual review of the financial results of Shanghai No. 1 Pharmaceutical Company Limited versus Sapporo Clinical Laboratory Inc., C & O Pharmaceutical Technology ( Holdings) Ltd and Zhejiang Zhenyuan Co., Ltd.. The comparative analysis of these companies compares Sales (sales, sales growth and sales per employee), Company Valuations (Price/Earnings, Price/Book, Price/Sales and 52-Week Price Change) and Financial Position (Long-term Debt/Equity). Also included for Shanghai No. 1 Pharmaceutical Company Limited are the Company Description, Recent Stock Performance, Profitability Analysis, Dividend Analysis, and Key Data Items (Ticker, Major Industry, Sub-Industry, Fiscal Year End Month, Employees, Share Type, Market Capitalization, Total Shares Outstanding and Number of Closely Held Shares.) Additional research for Shanghai No. 1 Pharmaceutical Company Limitedincludes tables with up to 10-years of history of computed ratios, sales, earnings, and security prices.
This product typically includes the following sections:
- Company Profile
- Comparative Business Analysis
- Summary Analysis per Share
- Sales Analysis
- Price Analysis
- Earnings and Dividends Analysis
Financial Statement Analyses
- Balance Sheet - Common Size
- Balance Sheet - Year-Year Percent Change
- Balance Sheet - Five-Year Averages-
- Income Statement - Common Size
- Income Statement - Year-Year Percent Change
- Income Statement - Five-Year Averages-
- Sources of Capital
Financial Ratio Analyses
- Accounting Ratios---
- Asset Utilization---
- Employee Efficiency--
- Fixed Charges Coverage
- Leverage Analysis
- Liquidity Analysis---
- Per-Share Data
- Profitability Analysis
Wright Quality Rating Analyses
- Investment Acceptance
- Financial Strength
- Profitability and Stability
- Corporate Growth
- Report is included when there are five or more years of data history.
-- Report is included when employee counts are available.
---These reports are not produced for Financial Companies.
Sapporo Clinical Laboratory Inc., C & O Pharmaceutical Technology ( Holdings) Ltd and Zhejiang Zhenyuan Co., Ltd.
A sample for this product is available. Please Login/Register to download this sample.